-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Sign up for news updates
Fred Hutchinson Cancer Research Center
-
Fred Hutchinson’s New President, Director
Posted: April 16, 2020 Dr. Thomas J. Lynch Jr. has been named the new president and director of the Fred Hutchinson Cancer Research Center. Most recently Dr. Lynch was chief scientific officer at Bristol- Myers Squibb, where he oversaw research and development for oncology, cardiovascular disease, fibrosis, and immunoscience. Previously chairman and CEO of Massachusetts…
View ILCN Archives
Provider Resources
Popular Articles